ProQR Therapeutics (PRQR) Total Debt (2021 - 2025)

ProQR Therapeutics' Total Debt history spans 4 years, with the latest figure at $4.9 million for Q4 2024.

  • For Q4 2024, Total Debt rose 6.03% year-over-year to $4.9 million; the TTM value through Dec 2024 reached $4.9 million, up 6.03%, while the annual FY2024 figure was $5.0 million, 6.82% up from the prior year.
  • Total Debt for Q4 2024 was $4.9 million at ProQR Therapeutics, up from $4.6 million in the prior quarter.
  • Across five years, Total Debt topped out at $50.4 million in Q4 2021 and bottomed at $4.6 million in Q4 2023.
  • The 4-year median for Total Debt is $5.9 million (2022), against an average of $16.7 million.
  • The largest annual shift saw Total Debt plummeted 86.3% in 2022 before it grew 6.03% in 2024.
  • A 4-year view of Total Debt shows it stood at $50.4 million in 2021, then tumbled by 86.3% to $6.9 million in 2022, then tumbled by 33.15% to $4.6 million in 2023, then rose by 6.03% to $4.9 million in 2024.
  • Per Business Quant, the three most recent readings for PRQR's Total Debt are $4.9 million (Q4 2024), $4.6 million (Q4 2023), and $6.9 million (Q4 2022).